Live from the NIH registry
Studies recruiting near Elkhart right now
Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: NRG Oncology
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute LAO
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Midwest Cardiovascu Rsrch Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Novo Nordisk A/S
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Boehringer Ingelheim
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: Akero Therapeutics, Inc
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Phase 2
Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: OHB Neonatology Ltd.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Nephrology Physician's LLC — Mishawaka, Indiana (10.3 mi)
· Sponsor: CSL Behring
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Mirati Therapeutics Inc.
An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention
Adolescent, Psychopathology
N/A
Interventional 900 participants sought
University of NotreDame — Notre Dame, Indiana (14.2 mi)
· Sponsor: University of Notre Dame
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: Hoffmann-La Roche
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 3
Interventional 486 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: NRG Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Memorial Regional Cancer Center Day Road — Mishawaka, Indiana (10.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Tempus AI
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: Akero Therapeutics, Inc
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Phase 2
Interventional 80 participants sought
Site 14 — Goshen, Indiana (10.0 mi)
· Sponsor: Corcept Therapeutics
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Cancer
N/A
Observational 500 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Tempus AI
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Alcohol Use Disorder, Opioid Use Disorder
N/A
Interventional 60 participants sought
The University of Notre Dame — Notre Dame, Indiana (14.2 mi)
· Sponsor: University of Notre Dame